SUCCESSFUL USE OF THE HEPARINOID DANAPAROID-SODIUM DURING AORTIC-VALVE PROTHESIS REPLACEMENT IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II

The 29-year-old, heroin-addicted patient received an aortic valve prot hesis (SJM) 10 years ago because of aortic valve stenosis III. One yea r after surgical treatment he refused to take Phenprocoumon and thus r eceived no anticoagulation for 9 years. The patient was hospitalized d ue to cardial decompensation and thrombosis of the aortic valve prothe sis was diagnosed. Under heparinization, he developed heparin-induced thrombocytopenia type II, which disappeared after changing the medicat ion to Danaparoid-Sodium. In order to avoid any further heparin exposu re, we also carried out the surgical replacement of the aortic valve p rothesis under anticoagulation with Danaparoid-Sodium.